Clinical Trials Browser

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Clinical Trials

MVX-ONCO-2 in Advanced Solid Tumors

ImmuCCo

Okgyn1

Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies

Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion

CTC-CEC-ADN

PACPAC-EPOC

MEDIPAC

ODORAJA

Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

CASTLE-11

NeoTIL in Advanced Solid Tumors

MoST-TAP

Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC

SprayDye

Anti-cancer DC Cell Vaccination to Treat Solid Tumors

Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors

Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors

Development and Application Study of ePRO Software for Managing Cancer Patients Throughout the Treatment Period

Expanded Access Neoantigen Vaccine in Solid Tumors

RACIN

Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study

Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors

Fluoride-labeled Boronophenylalanine PET Imaging in Patients With Solid Tumors

Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors

TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors

Circulating Tumor Cells in Solid Tumors

IMPRESS

QdV-ONCOREA

Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors

Safety Study of 89Zr-NY001 PET Imaging in Patients

89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors

Yoga for Solid Tumor

K-BASKET, TAS-117, PI3K/AKT Gene Aberration

RET-HE

Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors

A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer

Advanced Refractory Solid Tumors With TP53 Mutations Register Study

CPV2-0

Personalized Therapy of Molecular Tumor Board Participation With the Guidance of Next Generation Sequencing

18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR

89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors

Study of PD-1 Gene-knocked Out Mesothelin-directed CAR-T Cells With the Conditioning of PC in Mesothelin Positive Multiple Solid Tumors

RESIL